Get the Stockscreener App
1.13
8.38%
0.09
After Hours:
1.12
-0.010
-0.88%
Tilray Brands Inc stock is traded at $1.13, with a volume of 45.35M.
It is up +8.38% in the last 24 hours and down -17.12% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$1.04
Open:
$1.07
24h Volume:
45.35M
Relative Volume:
1.29
Market Cap:
$1.05B
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-3.7667
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
+0.64%
1M Performance:
-17.12%
6M Performance:
-43.92%
1Y Performance:
-40.67%
1-Day Range:
$1.05
$1.15
1-Week Range:
$1.03
$1.18
52-Week Range:
$1.03
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.13 | 1.05B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
172.80 | 78.39B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.69 | 43.65B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
HLN
Haleon Plc Adr
|
9.57 | 43.41B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.83 | 20.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
153.29 | 15.53B | 2.24B | 385.90M | 440.10M | 3.73 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Cannabis Stocks To Keep An Eye OnJanuary 30th - MarketBeat
Tilray Brands (TLRY) Stock Drops Amidst Broader Pharma Sector De - GuruFocus.com
Looking Into Tilray Brands's Recent Short Interest - Benzinga
The Main Reason Canadian Cannabis Stocks Are Falling - New Cannabis Ventures
Tilray (NASDAQ:TLRY) Hits New 12-Month LowHere's Why - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 2.2%Should You Sell? - MarketBeat
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Can Canada Maintain Its Cannabis Edge After Trudeau's Departure? - Benzinga
Tilray (NASDAQ:TLRY) Trading Down 1.4%Time to Sell? - MarketBeat
Tilray stock touches 52-week low at $1.06 amid market challenges - MSN
Tilray stock touches 52-week low at $1.13 amid market challenges - MSN
Tilray (NASDAQ:TLRY) Shares Down 1.4%What's Next? - MarketBeat
Tilray (NASDAQ:TLRY) Reaches New 52-Week LowHere's What Happened - MarketBeat
Tilray Brands Inc. stock falls Monday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Down 2.2%What's Next? - MarketBeat
Get Ready for the Ultimate Game Day with Tilray Brands: Nationwide Brewery Events! - GlobeNewswire
Where Will Tilray Brands Be in 5 Years? - MSN
Tilray (NASDAQ:TLRY) Stock Price Up 2.2%Here's Why - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 1.3%Time to Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 2.1%Here's What Happened - MarketBeat
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Shares Down 1.3%Here's Why - MarketBeat
Tilray Brands Inc (TLRY-Q) QuotePress Release - The Globe and Mail
Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA - Markets Insider
Tilray (NASDAQ:TLRY) Shares Down 2.1%Time to Sell? - MarketBeat
Tilray Brands Has Diversified Its Business Through Alcohol, but Is the Stock a Better Buy Than It Was 5 Years Ago? - AOL
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Down 2.1%Here's Why - MarketBeat
(01/21/25) Top Picks 2025: Tilray Brands (TLRY) - Moneyshow.com
Craft Beer Market Size to is Expected to Reach USD 242.79 billion by 2033, at a CAGR of 9.5% | Straits Research - GlobeNewswire Inc.
Cannabis Stocks To Follow NowJanuary 20th - MarketBeat
Tilray Q2 Earnings: What’s the Plan Here? - The Deep Dive
Tilray (NASDAQ:TLRY) Trading 0.8% HigherStill a Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Up 1.3%Should You Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Trading Up 2.1%Still a Buy? - MarketBeat
Tilray Brands (TSE:TLRY) Sets New 52-Week LowHere's Why - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 1.7%Should You Sell? - MarketBeat
Tilray Brands (TLRY) Stock Declines Following Q4 Earnings - GuruFocus.com
Roth Capital Has Bearish Estimate for Tilray FY2025 Earnings - MarketBeat
Tilray Brands (TSE:TLRY) Hits New 12-Month LowHere's Why - MarketBeat
Tilray has price target chopped at Haywood - Cantech Letter
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):